Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets
- 19 January 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 119 (3) , e9-e21
Abstract
Nodal marginal zone lymphoma (NMZL) is a small B-cell neoplasm whose molecular pathogenesis is still essentially unknown and whose differentiation from other small B-cell lymphomas is hampered by the lack of specific markers. We have analyzed gene expression, miRNA profile, and copy number data from 15 NMZL cases. For comparison, 16 follicular lymphomas (FLs), 9 extranodal marginal zone lymphomas, and 8 reactive lymph nodes and B-cell subtypes were included. The results were validated by quantitative RT-PCR in an independent series, including 61 paraffin-embedded NMZLs. NMZL signature showed an enriched expression of gene sets identifying interleukins, integrins, CD40, PI3K, NF-κB, and TGF-β, and included genes expressed by normal marginal zone cells and memory B cells. The most highly overexpressed genes were SYK, TACI, CD74, CD82, and CDC42EP5. Genes linked to G2/M and germinal center were down-regulated. Comparison of the gene expression profiles of NMZL and FL showed enriched expression of CHIT1, TGFB1, and TACI in NMZL, and BCL6, LMO2, and CD10 in FL. NMZL displayed increased expression of miR-221, miR-223, and let-7f, whereas FL strongly expressed miR-494. Our study identifies new candidate diagnostic molecules for NMZL and reveals survival pathways activated in NMZL.Keywords
This publication has 38 references indexed in Scilit:
- Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcomeBlood, 2011
- Identification of MNDA as a new marker for nodal marginal zone lymphomaLeukemia, 2009
- The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomasBlood, 2009
- Frequent inactivation of A20 in B-cell lymphomasNature, 2009
- Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomasBlood, 2008
- Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysisBlood, 2005
- Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organsBMC Immunology, 2004
- 7q31-32 Allelic Loss Is a Frequent Finding in Splenic Marginal Zone LymphomaThe American Journal of Pathology, 1999
- Human marginal-zone B cellsImmunology Today, 1998
- Monocytoid B‐cell lymphoma, a tumour related to the marginal zoneHistopathology, 1988